The University of Colorado Anschutz Gates Institute has received Investigational New Drug clearance from the U.S. Food and Drug Administration, marking the first chimeric antigen receptor (CAR) T-cell ...
The single-site, first-in-human Phase I trial will assess whether the therapy can kill cancer cells in patients who have become resistant to Venclexta.
Drexel University granted its first graduate degree in 1927. Since then, countless CEOs, astronauts, researchers, and leaders across all industries have become part of our ongoing legacy of success.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results